Long-term efficacy of baricitinib in patients with severe alopecia areata: week-52 results from BRAVE-AA1 and BRAVE-AA2
Year: 2022
Type: conference-abstract
Language: English
Topic: Hair Growth and Disorders
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7198519635
